NEW YORK, March 14, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Caribou Biosciences, Inc. (NASDAQ: CRBU) alleging that the Company violated federal securities laws.
This lawsuit is on behalf of persons and entities that purchased or otherwise acquired: (a) Caribou common stock pursuant and/or traceable to documents issued in connection with the Company's initial public offering conducted on or about July 23, 2021; and/or (b) Caribou securities between July 23, 2021, and December 9, 2022.
Lead Plaintiff Deadline: April 11, 2023
No obligation or cost to you.
Learn more about your recoverable losses in CRBU:
https://www.kleinstocklaw.com/pslra-1/caribou-biosciences-inc-loss-submission-form?id=37238&from=4
Caribou Biosciences, Inc. NEWS - CRBU NEWS
CLASS ACTION CASE DETAILS: The filed complaint alleges that Caribou Biosciences, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the treatment effect of the Company's product candidate, CB-010, was not as durable as defendants had led investors to believe; (ii) accordingly, CB-010's clinical and commercial prospects were overstated; and (iii) as a result, documents issued in connection with Caribou's initial public offer and defendants' public statements throughout the class period were materially false and/or misleading and failed to state information required to be stated therein.
WHAT THIS MEANS TO YOU AS A SHAREHOLDER: If you have suffered a loss in Caribou you have until April 11, 2023 to petition the court for lead plaintiff status. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
NO COST TO YOU: If you purchased Caribou securities during the relevant period, you may be entitled to compensation without payment of any out-of-pocket fees.
HOW TO PROTECT YOUR FINANCIAL INTERESTS: For additional information about the CRBU lawsuit, please contact J. Klein, Esq. by telephone at 212-616-4899 or click this link: https://www.kleinstocklaw.com/pslra-1/caribou-biosciences-inc-loss-submission-form?id=37238&from=4.
ABOUT KLEIN LAW FIRM
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. The Klein Law Firm is a boutique litigation firm with experience in a wide range of areas including securities law, corporate finance and commercial litigation. Since 2011, our experienced attorneys have achieved superior results for our clients with a personalized focus. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
535 Fifth Avenue
4th Floor
New York City, NY 10017
jk@kleinstocklaw.com
Telephone: (212) 616-4899
www.kleinstocklaw.com
View original content:https://www.prnewswire.com/news-releases/crbu-alert-the-klein-law-firm-announces-a-lead-plaintiff-deadline-of-april-11-2023-in-the-class-action-filed-on-behalf-of-caribou-biosciences-inc-shareholders-301770879.html
SOURCE The Klein Law Firm
